Pricing Log in Create free account
Friday 6 November 2026 Export BNTX’s income statement to Excel — free account

BioNTech SE Sponsored ADR

BNTX Healthcare Biotechnology

BioNTech SE Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 9.07% from fiscal 2024.

Revenue
−16.4%
EPS
+708.4%
Free cash flow
−123.8%
Total debt
+44.4%

Quarter to September 2026, against a year earlier

87.18 1.32 +1.54%
Market cap
$21.6B
P/E
0.0×
Fwd P/E
−13.5×
Dividend yield
—
F-score
4/9
Altman Z
n/a
Beneish M
−2.74
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

BioNTech SE Sponsored ADR (BNTX) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, BioNTech SE Sponsored ADR (BNTX) trades at a EV/Sales of 1.8×. Over the past ten years it has ranged from 0.0× (September 2020) to 160× (December 2020); the current reading is higher than 52% of that period. That is below the Biotechnology industry median of 9.0× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.0× (37.51%)
FY2024 3.2× 41.07%
FY2023 2.3× 91.40%
FY2022 1.2× (56.33%)
FY2021 2.7× (91.68%)
FY2020 32.5× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.0× 31.89%
Jun 2026 2.2× 24.67%
Mar 2026 1.8× (10.06%)
Dec 2025 2.0× 2.22%
24 more quarters

Against its own ten years

Low 0.0× High 160×
Ten-year median 1.7×
Current reading's percentile 45

EV/Sales against peers

Company EV/Sales
BNTX BioNTech SE Sponsored ADR 1.8×
INCY Incyte Corporation compare 3.4×
ALNY Alnylam Pharmaceuticals, Inc. compare 3.7×
EXEL Exelixis, Inc. compare 6.5×
GMAB Genmab A/S Sponsored ADR compare 8.7×
ASND Ascendis Pharma A/S compare 13.1×
INSM Insmed, Inc. compare 15.4×
BBIO BridgeBio Pharma, Inc. compare 15.9×
ROIV Roivant Sciences Ltd. compare 3,061×
Biotechnology industry median 9.0×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on BNTX